Earlier today, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) announced its exchange offer involving a mix of cash for the common stock of Allergan, Inc. (NYSE:AGN).
The offer is scheduled to expire on August 15, 2014.
Valeant’s hostile offer
As reported earlier, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) has officially indicated it’s going hostile on Allergan, Inc. (NYSE:AGN). In its presentation on Monday, Valeant said it was correcting ‘recent misrepresentations’ and refuting ‘misleading assertions made by Allergan, Inc. and others’.
As part of its four step process towards a merger with Allegan, Valeant launched its first step through today’s exchange offer. Allergan...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
